| http://www.w3.org/ns/prov#value | - 1Albert Einstein Coll of Med, Bronx, NY, US; 2Univ of Utah, Salt Lake City, US; 3CDC, Atlanta, GA, US; and 4ImQuest BioSci, Frederick, MD, US Background: The lack of biomarkers predictive of efficacy and safety is a major gap in topical pre-exposure prophylaxis (PrEP) development.
|
